Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial.

BMC Nephrol · 2019 · PMC6731553 · PMID 31492152

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

The median time to remission (CR/PR) in the TAC group was 54 weeks compared to 40 weeks in the TAC/MMF group, suggesting a possible trend to earlier remission in the TAC/MMF group, but this was not statistically significant ( p = 0.46).

also in 1,410 other papers

did not reach statistical significanceno p-value reported

The trend of the TAC/MMF group to achieve remission sooner than the TAC alone group did not reach statistical significance but it perhaps suggests that in some patients the addition of MMF to TAC may have some effect in achieving effective remission faster.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.